Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Daily volatility influences return paths and allocation choices. This primer covers interpretation and practical tweaks to targets and expectations.
25,212 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Pershing Square signals a bold bet by leaning into Microsoft as the AI and cloud wave reshapes enterprise tech. The m...
A retiring executive with a $4+ million 401K and a heavy concentration in employer stock faces a potential tax trap. ...
Small-cap biotech Aethlon Medical faces a pivotal year in 2026. This guide breaks down what to watch in aethlon (aemd...
A pivotal hearing in New York tests the CLARITY Act as Congress debates crypto rules. BTC, ETH and XRP face a regulat...
Bitcoin holds near $61,000 and Ether sits above $1,700 as softer jobs data cools rate-hike fears. Spot Bitcoin ETFs r...
SpaceX’s IPO frenzy has cooled, dragging crypto-linked bets with it. A looming unlock window, plus a sharp pullback i...
C3.ai reports after the bell, with traders watching for signals on revenue, margins and AI platform uptake. This live...
Global defense markets are shifting as the US, Russia, and China advance missile programs. This report examines inves...
A well-known AI stock has retraced roughly a quarter from its high, creating a potential entry point for investors. T...
Gold retreats while Bitcoin-focused ETFs keep drawing capital, highlighting a widening split in how investors price i...
President Trump is set to land in Beijing on May 14, asserting economic leverage as oil markets whirl. China’s reserv...